# Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery

> **NCT02407626** · NA · TERMINATED · sponsor: **Triemli Hospital** · enrollment: 2 (actual)

## Conditions studied

- Myocardial Ischemia

## Interventions

- **DRUG:** Propofol
- **DRUG:** Sevoflurane

## Key facts

- **NCT ID:** NCT02407626
- **Lead sponsor:** Triemli Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09
- **Primary completion:** 2018-03-07
- **Final completion:** 2018-03-07
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Very low patient recruitment, changed insurance requirements
- **Last updated:** 2018-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02407626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02407626, "Optimization of Cardioprotection in Diabetic Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02407626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*